文献速递小儿神经外科与脑积水

脑室分流管耐久性与成本的对比分析

Comparative durability and costs analysis of ventricular shunts.
PubMed 文献 · J Neurosurg · 2018-05-11

回顾性分析3年内417例成人脑室分流术患者,比较固定压力阀与可调压阀的耐久性和成本。可调压阀与固定压力阀的翻修率相似(22% vs 21%,HR 1.1 [95%CI 0.6-1.8]),耐久性无差异(p=0.980),但可调压阀的供应成本更高(中位数3438美元 vs 1504美元,p<0.001)。假性脑瘤和既往分流故障显著增加翻修风险。

要点

  • 可调压阀与固定压力阀的翻修率相似(22% vs 21%,HR 1.1 [95%CI 0.6-1.8])。
  • 固定压力阀与可调压阀的耐久性无差异(平均39个月 vs 40个月,p=0.980)。
  • 可调压阀的供应成本中位数高于固定压力阀(3438美元 vs 1504美元,p<0.001)。

核心结论

  • 在成人患者中,固定压力阀与可调压阀的长期分流翻修率相似。
  • 脑积水病因可能对预测分流翻修有重要作用,而可调压阀无论初始诊断如何均产生更高的供应成本。
  • 使用固定压力阀而非可调压阀可能降低供应成本,同时保持相似的翻修率。
  • 鉴于制定成本效益管理方案的重要性,本研究强调迫切需要对脑室分流阀翻修及其他以患者为中心的结局进行大规模前瞻性观察研究和随机临床试验。

研究设计与样本

  • 回顾性审查2013年8月至2016年10月3年期间在本机构因脑积水接受脑室分流管植入术的所有患者病历,术后最低随访6个月。
  • 共纳入417例患者,其中固定压力阀62例(15%),可调压阀355例(85%)。
  • 主要结局为分流翻修,定义为初始手术后因任何指征再次手术。
  • 比较固定阀与可调压阀的供应成本、分流耐久性和脑积水病因。

主要发现

  • 平均随访30±12(标准差)个月。
  • 可调压阀的翻修率为22%,固定压力阀为21%(HR 1.1 [95%CI 0.6-1.8])。
  • 分流并发症(如阀故障、感染和过度引流)在各阀类型间发生频率相似。
  • Kaplan-Meier生存曲线分析显示固定阀(平均39个月)与可调压阀(平均40个月)的耐久性无差异(p=0.980,log-rank检验)。
  • 计入后续翻修后,可调压阀的每例指数病例分流供应成本中位数为3438美元(四分位距2938-3876美元),固定压力阀为1504美元(四分位距753-1584美元)(p<0.001,Wilcoxon秩和检验)。

关键数值与推荐

  • 可调压阀翻修率22% vs 固定压力阀21%(HR 1.1 [95%CI 0.6-1.8])。
  • 固定阀平均耐久性39个月 vs 可调压阀40个月(p=0.980,log-rank检验)。
  • 可调压阀供应成本中位数3438美元(四分位距2938-3876美元)vs 固定压力阀1504美元(四分位距753-1584美元)(p<0.001,Wilcoxon秩和检验)。
  • 假性脑瘤的翻修风险HR 1.9(95%CI 1.2-3.1),既往分流故障的翻修风险HR 1.8(95%CI 1.2-2.7)。

临床怎么用

  • 作者认为,使用固定压力阀而非可调压阀可能降低供应成本,同时保持相似的翻修率。
  • 作者指出,脑积水病因可能对预测分流翻修有重要作用。
  • 作者强调迫切需要对脑室分流阀翻修及其他以患者为中心的结局进行大规模前瞻性观察研究和随机临床试验。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Ventricular shunt (VS) durability has been well studied in the pediatric population and in patients with normal pressure hydrocephalus; however, further evaluation in a more heterogeneous adult population is needed. This study aims to evaluate the effect of diagnosis and valve type-fixed versus programmable-on shunt durability and cost for placement of shunts in adult patients. METHODS: The authors retrospectively reviewed the medical records of all patients who underwent implantation of a VS for hydrocephalus at their institution over a 3-year period between August 2013 and October 2016 with a minimum postoperative follow-up of 6 months. The primary outcome was shunt revision, which was defined as reoperation for any indication after the initial procedure. Supply costs, shunt durability, and hydrocephalus etiologies were compared between fixed and programmable valves. RESULTS: A total of 417 patients underwent shunt placement during the index time frame, consisting of 62 fixed shunts (15%) and 355 programmable shunts (85%). The mean follow-up was 30 ± 12 (SD) months. The shunt revision rate was 22% for programmable pressure valves and 21% for fixed pressure valves (HR 1.1 [95% CI 0.6-1.8]). Shunt complications, such as valve failure, infection, and overdrainage, occurred with similar frequency across valve types. Kaplan-Meier survival curve analysis showed no difference in durability between fixed (mean 39 months) and programmable (mean 40 months) shunts (p = 0.980, log-rank test). The median shunt supply cost per index case and accounting for subsequent revisions was $3438 (interquartile range $2938-$3876) and $1504 (interquartile range $753-$1584) for programmable and fixed shunts, respectively (p < 0.001, Wilcoxon rank-sum test). Of all hydrocephalus etiologies, pseudotumor cerebri (HR 1.9 [95% CI 1.2-3.1]) and previous shunt malfunction (HR 1.8 [95% CI 1.2-2.7]) were found to significantly increase the risk of shunt revision. Within each diagnosis, there were no significant differences in revision rates between shunts with a fixed valve and shunts with a programmable valve. CONCLUSIONS: Long-term shunt revision rates are similar for fixed and programmable shunt pressure valves in adult patients. Hydrocephalus etiology may play a significant role in predicting shunt revision, although programmable valves incur higher supply costs regardless of initial diagnosis. Utilization of fixed pressure valves versus programmable pressure valves may reduce supply costs while maintaining similar revision rates. Given the importance of developing cost-effective management protocols, this study highlights the critical need for large-scale prospective observational studies and randomized clinical trials of ventricular shunt valve revisions and additional patient-centered outcomes.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Agarwal N, Kashkoush A, McDowell MM, et al. Comparative durability and costs analysis of ventricular shunts. J Neurosurg. 2018. PMID: 29749912. doi:10.3171/2017.11.JNS172212

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。